Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels

American Journal of Cardiology

Volumn 112, Issue 9, 2013, Pages 1499-1504

  Scoffone, Heather M ^a,b   Krajewski, Megan ^b   Zorca, Suzana ^b   Bereal Williams, Candice ^b   Littel, Patricia ^b   Seamon, Catherine ^b   Mendelsohn, Laurel ^b   Footman, Eleni ^b   Abi Jaoudeh, Nadine ^c   Sachdev, Vandana ^b   Machado, Roberto F ^b,c   Cuttica, Michael ^c   Shamburek, Robert ^b   Cannon III, Richard O ^b   Remaley, Alan ^b   Minniti, Caterina P ^b   Kato, Gregory J ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD VESSEL FUNCTION; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; ENDOTHELIAL FUNCTION; FEMALE; FLUSHING; HUMAN; HYPOTHESIS; LIPOPROTEIN BLOOD LEVEL; MALE; PHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; CHOLESTEROL, HDL; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; NIACIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATION; YOUNG ADULT;

EID: 84885953035     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.06.035     Document Type: Article

References (26)

1. S. Yuditskaya, A. Tumblin, G.T. Hoehn, G. Wang, S.K. Drake, X. Xu, S. Ying, A.H. Chi, A.T. Remaley, R.F. Shen, P.J. Munson, A.F. Suffredini, and G.J. Kato Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease Blood 113 2009 1122 1128
2. S. Zorca, L. Freeman, M. Hildesheim, D. Allen, A.T. Remaley, J.G. Taylor, and G.J. Kato Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension Br J Haematol 149 2010 436 445
3. G.A. Heresi, M. Aytekin, J. Newman, J. DiDonato, and R.A. Dweik Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension Am J Respir Crit Care Med 182 2010 661 668
4. M.A. Al-Mohaissen, S.C. Pun, and J.J. Frohlich Niacin: from mechanisms of action to therapeutic uses Mini Rev Med Chem 10 2010 204 217
5. V.S. Kamanna, and M.L. Kashyap Mechanism of action of niacin Am J Cardiol 101 2008 20B 26B
6. I.J. Grek, and M. Findlay Sickle cell anaemia; report of a case with a note on therapy S Afr Med J 25 1951 780 784
7. J.T. Kuvin, M.E. Ramet, A.R. Patel, N.G. Pandian, M.E. Mendelsohn, and R.H. Karas A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression Am Heart J 144 2002 165 172
8. M.T. Gladwin, A.N. Schechter, F.P. Ognibene, W.A. Coles, C.D. Reiter, W.H. Schenke, G. Csako, M.A. Waclawiw, J.A. Panza, and R.O. Cannon III Divergent nitric oxide bioavailability in men and women with sickle cell disease Circulation 107 2003 271 278
9. M.T. Gladwin, and E. Vichinsky Pulmonary complications of sickle cell disease N Engl J Med 359 2008 2254 2265
10. D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan, J.K. Lloyd, and J.E. Deanfield Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
11. A.K. Faizi, D.W. Kornmo, and S. Agewall Evaluation of endothelial function using finger plethysmography Clin Physiol Funct Imaging 29 2009 372 375
12. T.A. Barringer, L. Hatcher, and H.C. Sasser Potential benefits on impairment of endothelial function after a high-fat meal of 4 weeks of flavonoid supplementation Evid Based Complement Alternat Med 2011 2011 796958
13. L. Belhassen, G. Pelle, S. Sediame, D. Bachir, C. Carville, C. Bucherer, C. Lacombe, F. Galacteros, and S. Adnot Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation Blood 97 2001 1584 1589
14. R.T. Eberhardt, L. McMahon, S.J. Duffy, M.H. Steinberg, S.P. Perrine, J. Loscalzo, J.D. Coffman, and J.A. Vita Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels Am J Hematol 74 2003 104 111
15. C. Bereal-Williams, R.F. Machado, V. McGowan 2nd, A. Chi, C.J. Hunter, G.J. Kato, L. Hunter, C.K. Dalby, K.P. Hauser, A. Tailor, and R.O. Cannon III Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia Haematologica 97 2012 1768 1770
16. C.S. Vaccari, S. Nagamia, M. Thoenes, A. Oguchi, R. Hammoud, and B.V. Khan Efficacy of controlled-release niacin in treatment of metabolic syndrome: correlation to surrogate markers of atherosclerosis, vascular reactivity, and inflammation J Clin Lipidol 1 2007 605 613
17. S. Westphal, K. Borucki, E. Taneva, R. Makarova, and C. Luley Extended-release niacin raises adiponectin and leptin Atherosclerosis 193 2007 361 365
18. M. Thoenes, A. Oguchi, S. Nagamia, C.S. Vaccari, R. Hammoud, G.E. Umpierrez, and B.V. Khan The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome Int J Clin Pract 61 2007 1942 1948
19. T.C. Andrews, E.J. Whitney, G. Green, R. Kalenian, and B.E. Personius Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl Am J Cardiol 80 1997 831 835
20. A. Warnholtz, P. Wild, M.A. Ostad, V. Elsner, F. Stieber, R. Schinzel, U. Walter, D. Peetz, K. Lackner, S. Blankenberg, and T. Munzel Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study Atherosclerosis 204 2009 216 221
21. A.M. Benjo, R.C. Maranhao, S.R. Coimbra, A.C. Andrade, D. Favarato, M.S. Molina, L.I. Brandizzi, and P.L. da Luz Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment Atherosclerosis 187 2006 116 122
22. J.J. Kelly, J.A. Lawson, L.V. Campbell, L.H. Storlien, A.B. Jenkins, J.A. Whitworth, and A.J. O'Sullivan Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects J Hum Hypertens 14 2000 567 572
23. S.J. Hamilton, G.T. Chew, T.M. Davis, and G.F. Watts Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients Diab Vasc Dis Res 7 2010 296 299
24. P.M. Lavigne, and R.H. Karas The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression J Am Coll Cardiol 61 2013 440 446
25. C.J. Lavie, J.J. Dinicolantonio, R.V. Milani, and J.H. O'Keefe Niacin therapy lives for another day-maybe? J Am Coll Cardiol 61 2013 2197 2198
26. D. Darghouth, B. Koehl, G. Madalinski, J.F. Heilier, P. Bovee, Y. Xu, M.F. Olivier, P. Bartolucci, M. Benkerrou, S. Pissard, Y. Colin, F. Galacteros, G. Bosman, C. Junot, and P.H. Romeo Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome Blood 117 2011 e57 e66